expression. Post-mortem human alcoholic brain shows increased levels of neuroimmune genes consistent with ethanol-induced neuroinflammation. In brain slice cultures, exogenous IL-1beta, TNFalpha and MCP1 reduce neurogenesis. Neutralizing antibodies to IL-1beta added to slice cultures increased neurogenesis and completely reversed ethanol inhibiton of neurogenesis. Exogenous IL-1 receptor antagonist, IL-1RIa, also blocked ethanol inhibition of neurogenesis, suggesting that IL-1beta mediates ethanol inhibition of neurogenesis. A number of drugs reverse ethanol inhibition of neurogenesis. Antidressants that are effective treatments of human depression reverse ethanol induction of IL1beta and stimulate neurogenesis. Drugs that blunt neuroimmune activation, block inflammasome formation or NFkappaB activation reverse ethanol inhibition of neurogenesis. These findings suggest that inflammasome induction and loss of neurogenesis contribute depression and negative affect. Antidepressants and anti-neuroinflammatory drugs reverse ethanol inhibition of neurogenesis through inhibition of In alcohol-dependent patients, alcohol-associated cues elicit brain activations in mesocorticolimbic networks related to the rewarding properties of the drug and were previously found to be associated with relapse behaviour. Functional magnetic resonance imaging (fMRI) was used to assess cue-reactivity during the presentation of alcohol-related pictures in 73 recently detoxified alcoholdependent patients before and after randomized double-blind treatment with naltrexone, acamprosate or placebo. Using Cox-regression we examined the effect of fMRI cue-reactivity and treatment on the time to the first severe relapse. In early abstinence, the activated network consisted of the ventral striatum, cingulate gyrus and prefrontal areas. After 2 weeks of treatment with naltrexone, acamprosate or placebo cue-elicited brain activity in the striatum and the thalamus was decreased in comparison with the first medication-free fMRI session. With increasing fMRI, cue-reactivity at the first fMRI session relapse risk was reduced in the Naltrexone compared with the Acamprosate group for the ventral striatum. Notably, remaining cue-induced brain activation in the ventral striatum during the second fMRI session was negatively associated with the time to first severe relapse. fMRI cue-reactivity can be used as a prognostic factor for relapse in alcohol-dependent patients. Alcohol-dependent patients with high fMRI cue-reactivity might especially benefit from Naltrexone treatment. [This work was supported by the DFG (He 2597/ 4-1&4-2; Sm 80/1-1) and the BMBF (01EB0110&01EB0410 km Dept. of Biological Psychiatry, Medical Univerx, Vienna, Austria Dopamine plays a preeminent role in acquisition and maintenance of addictive behaviour. Animal studies have identified firing of brainstem dopamine neurons and release of dopamine into the ventral striatum as essential neurochemical components of reward-learning processes. Sensitization is a process in which repeated intermittent exposure to a substance causes increased behavioural and neurochemical response after re-exposure to the substance. Sensitization is believed to contribute to the persisting vulnerability to relapse in alcohol-dependent patients. On a neurochemical level, it is associated with increased striatal dopamine release. Brain imaging methods such as positron emission tomography (PET) have provided substantial insight into dopaminergic alterations in alcohol dependence. Imaging the competition between dopamine and a radioligand at postsynaptic dopamine D2/3 receptors allows for measuring changes in endogenous dopamine levels in the living human brain. So far, studies on the competition of a radioligand with dopamine in humans used D2/3 antagonist radioligands. Dopamine D2/3 receptor agonist radioligands are a recent development with the major advantage that they are more sensitive towards fluctuations in endogenous dopamine than their D2/3 antagonist counterparts. The full agonist radioligand [ 11 C]-(+)-PHNO is currently the most sensitive ligand for detecting changes in extracellular dopamine levels in the living human brain. Here we propose to use [ 11 C]-(+)-PHNO and PET as the current method of choice for studying dopaminergic alterations in patients with alcohol dependence. The method might help to build a rationale for dopamine agonist treatment in alcohol dependence. Moreover, [
In alcohol-dependent patients, alcohol-associated cues elicit brain activations in mesocorticolimbic networks related to the rewarding properties of the drug and were previously found to be associated with relapse behaviour. Functional magnetic resonance imaging (fMRI) was used to assess cue-reactivity during the presentation of alcohol-related pictures in 73 recently detoxified alcoholdependent patients before and after randomized double-blind treatment with naltrexone, acamprosate or placebo. Using Cox-regression we examined the effect of fMRI cue-reactivity and treatment on the time to the first severe relapse. In early abstinence, the activated network consisted of the ventral striatum, cingulate gyrus and prefrontal areas. After 2 weeks of treatment with naltrexone, acamprosate or placebo cue-elicited brain activity in the striatum and the thalamus was decreased in comparison with the first medication-free fMRI session. With increasing fMRI, cue-reactivity at the first fMRI session relapse risk was reduced in the Naltrexone compared with the Acamprosate group for the ventral striatum. Notably, remaining cue-induced brain activation in the ventral striatum during the second fMRI session was negatively associated with the time to first severe relapse. fMRI cue-reactivity can be used as a prognostic factor for relapse in alcohol-dependent patients. Alcohol-dependent patients with high fMRI cue-reactivity might especially benefit from Naltrexone treatment. Dept. of Biological Psychiatry, Medical Univerx, Vienna, Austria Dopamine plays a preeminent role in acquisition and maintenance of addictive behaviour. Animal studies have identified firing of brainstem dopamine neurons and release of dopamine into the ventral striatum as essential neurochemical components of reward-learning processes. Sensitization is a process in which repeated intermittent exposure to a substance causes increased behavioural and neurochemical response after re-exposure to the substance. Sensitization is believed to contribute to the persisting vulnerability to relapse in alcohol-dependent patients. On a neurochemical level, it is associated with increased striatal dopamine release. Brain imaging methods such as positron emission tomography (PET) have provided substantial insight into dopaminergic alterations in alcohol dependence. Imaging the competition between dopamine and a radioligand at postsynaptic dopamine D2/3 receptors allows for measuring changes in endogenous dopamine levels in the living human brain. So far, studies on the competition of a radioligand with dopamine in humans used D2/3 antagonist radioligands. Dopamine D2/3 receptor agonist radioligands are a recent development with the major advantage that they are more sensitive towards fluctuations in endogenous dopamine than their D2/3 antagonist counterparts. The full agonist radioligand [ 11 C]-(+)-PHNO is currently the most sensitive ligand for detecting changes in extracellular dopamine levels in the living human brain. Here we propose to use [ 11 C]-(+)-PHNO and PET as the current method of choice for studying dopaminergic alterations in patients with alcohol dependence. The method might help to build a rationale for dopamine agonist treatment in alcohol dependence. Moreover, [
11 C]-(+)-PHNO may help to better understand sensitization and possibly even the dopaminergic response to alcohol-related environmental cues in relation to the risk of relapse. In summary, the dopamine D2/3 receptor agonist radioligand [
11 C]-(+)-PHNO has the potential to substantially advance our knowledge on dopaminergic mechanisms in reward learning and sensitization in patients with alcohol dependence. Alcoholism induces widespread yet selective damage of brain structure and disturbance of brain function that likely contributes to difficulty in sustaining sobriety and in achieving normal and efficient functioning. The multiple modalities of in vivo magnetic resonance imaging (MRI) provide noninvasive methods to characterize alcoholism-related brain alterations. When coupled with neuropsychological evaluations, explorations of in vivo brain structure and functional connectivity can reveal neural systems affected by alcoholism, and systems or loops invoked for compensation. Functional MRI (fMRI), structural MRI, diffusion tensor imaging and neuropsychological findings support central roles for frontocerebellar circuit alteration as underlying executive impairment related to alcoholism. We recently revealed the presence of a double-dissociation within frontocerebellar circuit characterized in alcoholics by some loops being structurally different from those of controls and others being similar. Functionally, preserved loops have been shown to compensate for damaged ones when alcoholics perform a challenging task. Specifically, through greater functional synchronization in the frontocerebellar motor loop, alcoholics were able to compensate for inefficient functioning of the parallel frontocerebellar executive loop. Another view of brain functioning derives from concepts of intrinsic functional networks, the most considered being the default-mode network (DMN). This large system becomes synchronously active when an individual is not stimulated by an external stimulus and thus is 'at rest'. We found that the spontaneous slow fluctuations of fMRI signals in regions of the DMN were less synchronized in alcoholics than in controls, indicative of compromised functional connectivity even when the brain is 'at rest'. Greater efficiency in several connections of this system correlated with longer sobriety in alcoholics. Thus, brain imaging tools have enabled in vivo investigation of insult to specific brain circuits that form the basis for pathophysiological models of alcoholism as a disconnection syndrome accompanied by processing inefficiency of functional networks in alcoholism. (This study was supported by U.S. National Institute of Health grants AA010723, AA012388, AA017168, and AA017923.) Downloaded from
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